DE69031351D1 - Zubereitungen und behandlungen von pneumonia in tieren - Google Patents

Zubereitungen und behandlungen von pneumonia in tieren

Info

Publication number
DE69031351D1
DE69031351D1 DE69031351T DE69031351T DE69031351D1 DE 69031351 D1 DE69031351 D1 DE 69031351D1 DE 69031351 T DE69031351 T DE 69031351T DE 69031351 T DE69031351 T DE 69031351T DE 69031351 D1 DE69031351 D1 DE 69031351D1
Authority
DE
Germany
Prior art keywords
haemolytica
pneumonia
antigens
disclosed
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69031351T
Other languages
English (en)
Other versions
DE69031351T2 (de
Inventor
Stephen Acres
Lorne Bariuk
Andrew Potter
Michael Lawman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Saskatchewan
Original Assignee
University of Saskatchewan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Saskatchewan filed Critical University of Saskatchewan
Publication of DE69031351D1 publication Critical patent/DE69031351D1/de
Application granted granted Critical
Publication of DE69031351T2 publication Critical patent/DE69031351T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69031351T 1990-04-05 1990-05-25 Zubereitungen und behandlungen von pneumonia in tieren Expired - Lifetime DE69031351T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50485090A 1990-04-05 1990-04-05
PCT/CA1990/000170 WO1991015237A1 (en) 1990-04-05 1990-05-25 Compositions and treatments for pneumonia in animals

Publications (2)

Publication Number Publication Date
DE69031351D1 true DE69031351D1 (de) 1997-10-02
DE69031351T2 DE69031351T2 (de) 1998-02-05

Family

ID=24008001

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69031351T Expired - Lifetime DE69031351T2 (de) 1990-04-05 1990-05-25 Zubereitungen und behandlungen von pneumonia in tieren

Country Status (8)

Country Link
EP (1) EP0527724B1 (de)
JP (1) JPH05508301A (de)
AT (1) ATE157258T1 (de)
AU (1) AU642650B2 (de)
DE (1) DE69031351T2 (de)
ES (1) ES2108693T3 (de)
FI (1) FI924457A (de)
WO (1) WO1991015237A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849531A (en) * 1989-04-07 1998-12-15 University Of Saskatchewan Compositions and treatments for pneumonia in animals
CA2014033C (en) * 1989-04-07 1993-02-09 Stephen D. Acres Compositions and treatments for pneumonia in animals
US6797272B1 (en) 1991-10-16 2004-09-28 University Of Saskatchewan Enhanced immunogenicity using leukotoxin chimeras
US5837268A (en) * 1991-10-16 1998-11-17 University Of Saskatchewan GnRH-leukotoxin chimeras
US5723129A (en) * 1991-10-16 1998-03-03 University Of Saskatchewan GnRH-leukotoxin chimeras
AU2699192A (en) * 1991-10-16 1993-05-21 University Of Saskatchewan Enhanced immunogenicity using leukotoxin chimeras
US5422110A (en) * 1991-10-16 1995-06-06 University Of Saskatchewan Enhanced immunogenicity using leukotoxin chimeras
MX9301736A (es) * 1992-03-30 1994-01-31 Smithkline Beecham Corp Vacuna de bacterina-toxoide de pasteurella haemolytica tipo a-1.
US5855894A (en) * 1992-03-30 1999-01-05 Pfizer Inc. Pasteurella haemolytica type A-1 bacterin-toxoid vaccine
US5534256A (en) * 1992-07-02 1996-07-09 University Of Saskatchewan Haemophilus somnus outer membrane protein extract enriched with iron-regulated proteins
US5441736A (en) * 1992-11-05 1995-08-15 University Of Saskatchewan Actinobacillus pleuropneumoniae outer membrane lipoprotein A and uses thereof
EP0751956A1 (de) * 1994-03-22 1997-01-08 Pfizer Inc. Pasteurellaceae antigene und verwandte impfstoffe
US6903184B1 (en) 1998-03-02 2005-06-07 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Multiple antigenic peptides immunogenic against Streptococcus pneumonia
AU758764B2 (en) * 1998-03-02 2003-03-27 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Epitope peptides immunogenic against (streptococcus pneumoniae)
US20100330158A1 (en) * 2009-03-31 2010-12-30 Innopharma, Llc Protein-assisted drug delivery system for the targeted administration of active agents
AU2010234193B2 (en) * 2009-04-06 2015-08-20 University Of Saskatchewan Methods and compositions for treating and preventing Shiga toxin-producing Escherichia coli infection

Also Published As

Publication number Publication date
ES2108693T3 (es) 1998-01-01
ATE157258T1 (de) 1997-09-15
FI924457A0 (fi) 1992-10-02
EP0527724B1 (de) 1997-08-27
AU5662190A (en) 1991-10-30
WO1991015237A1 (en) 1991-10-17
DE69031351T2 (de) 1998-02-05
AU642650B2 (en) 1993-10-28
EP0527724A1 (de) 1993-02-24
JPH05508301A (ja) 1993-11-25
FI924457A (fi) 1992-10-02

Similar Documents

Publication Publication Date Title
CA2014033A1 (en) Compositions and treatments for pneumonia in animals
DE69031351D1 (de) Zubereitungen und behandlungen von pneumonia in tieren
ATE120093T1 (de) Meningococcales klasse i-aussenmembranprotein- vakzin.
ATE127345T1 (de) Stressproteine und verwendungen dafür.
KR890701770A (ko) 호흡성 신시아 비루스 : 백신 및 진단검사법
NO913518L (no) Vaksiner for ikke typebestembar haemophilus influenzae.
PT815235E (pt) Vacinas para peste
NZ512574A (en) Novel streptococcus antigens useful as vaccines
LU91323I2 (fr) Vaccin papillomavirus humain Ätypes 6,11,16,18Ü(recombinant, adsorbé).-silgard
DE3886506D1 (de) Avirulente mikroben und deren verwendungen.
KR890701758A (ko) 재조합 dna에서 유도한 보르데텔라 외독소 소단위체의 유사체 및 그를 포함하는 백신
CA2022420A1 (en) Escherichia coli vaccine
DE69228944D1 (de) Bovines herpesvirus typ 1rekombinantenpolypeptide und vakzine
NO902251L (no) Fremstilling av gonoreiske p1-proteiner og vaksiner.
KR890006253A (ko) 가금류내의 E.coli septicaemia에 대한 백신
BR9306187A (pt) Vacina bacterin-toxóide pasteurella haemolytica tipo a-1
DE69123252D1 (de) Kreuzreaktive immunisierung gegen influenza
ZA888580B (en) New immunologically active synthetic peptides useful for preparing an antimalarial vaccine
RU93008069A (ru) Способ иммунизации крупного рогатого скота
Zourbas et al. Immunization of dental surgeons against hepatitis B virus infection.
CA2007248A1 (en) Meningococcal class 1 outer-membrane protein vaccine
NO923828L (no) Polypeptider, nyttige til diagnose av og behandling mot mycoplasma-infeksjoner hos dyr

Legal Events

Date Code Title Description
8364 No opposition during term of opposition